标题
Current trends in development of HDAC-based chemotherapeutics
作者
关键词
-
出版物
LIFE SCIENCES
Volume 308, Issue -, Pages 120946
出版商
Elsevier BV
发表日期
2022-09-10
DOI
10.1016/j.lfs.2022.120946
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hydroxamic Acid as a Potent Metal-Binding Group for Inhibiting Tyrosinase
- (2022) Joonhyeok Choi et al. Antioxidants
- Development of New Inhibitors of HDAC1–3 Enzymes Aided by In Silico Design Strategies
- (2022) Narges Cheshmazar et al. Journal of Chemical Information and Modeling
- Coupling Chlorin-Based Photosensitizers and Histone Deacetylase Inhibitors for Photodynamic Chemotherapy
- (2022) Lei Hou et al. MOLECULAR PHARMACEUTICS
- Strategies to Design Selective Histone Deacetylase Inhibitors
- (2021) Wolfgang Sippl et al. ChemMedChem
- Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium – an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879
- (2021) David I. Quinn et al. INVESTIGATIONAL NEW DRUGS
- Redefining the Histone Deacetylase Inhibitor Pharmacophore: High Potency with No Zinc Cofactor Interaction
- (2021) Douglas C. Beshore et al. ACS Medicinal Chemistry Letters
- Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
- (2021) Robert Jenke et al. Cancers
- Recent developments of HDAC inhibitors: Emerging indications and novel molecules
- (2021) Andrey D. Bondarev et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors
- (2021) Apostolia M. Tsimberidou et al. CLINICAL CANCER RESEARCH
- Design, synthesis and biological evaluation of selective histone deacetylase 6 (HDAC6) inhibitors bearing benzoindazole or pyrazoloindazole scaffold as surface recognition motif
- (2021) Qihao Xu et al. BIOORGANIC CHEMISTRY
- Rational design and development of HDAC inhibitors for breast cancer treatment
- (2021) Deepansh Mody et al. CURRENT PHARMACEUTICAL DESIGN
- Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist
- (2021) Xiangqian Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation
- (2021) Laura Márquez-Cantudo et al. MOLECULES
- Histone deacetylase 2 selective inhibitors: A versatile therapeutic strategy as next generation drug target in cancer therapy
- (2021) Manasa Gangadhar Shetty et al. PHARMACOLOGICAL RESEARCH
- HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
- (2021) Dimitris Karagiannis et al. Cancers
- Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer
- (2021) Norikazu Masuda et al. BMC CANCER
- Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy
- (2021) Mengjiao Zhou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular design of dual inhibitors of PI3K and potential molecular target of cancer for its treatment: A review
- (2021) Yuanze Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Designing HDAC-PROTACs: lessons learned so far
- (2021) Fabian Fischer et al. Future Medicinal Chemistry
- Discovery of potent HDAC2 inhibitors based on virtual screening in combination with drug repurposing
- (2021) Qiushuang Gao et al. JOURNAL OF MOLECULAR STRUCTURE
- Preclinical development of the class I selective histone deacetylase inhibitor OKI-179 for the treatment of solid tumors
- (2021) Jennifer R. Diamond et al. MOLECULAR CANCER THERAPEUTICS
- Potent Dual BET/HDAC Inhibitors for Efficient Treatment of Pancreatic Cancer
- (2020) Shipeng He et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Romidepsin (FK228), An Histone Deacetylase Inhibitor, and its Analogues in Cancer Chemotherapy.
- (2020) Eftiola Pojani et al. CURRENT MEDICINAL CHEMISTRY
- HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women
- (2020) Sara S. Oltra et al. Cancers
- Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid
- (2020) Mariah M. Hoffman et al. Cancers
- Characterization of a dual BET / HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma
- (2020) Xin Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
- (2020) Terence C. S. Ho et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance
- (2020) Jian Liu et al. ACS Medicinal Chemistry Letters
- Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
- (2020) Bin Tu et al. Frontiers in Cell and Developmental Biology
- Multitarget inhibition of histone deacetylase (HDAC) and phosphatidylinositol‐3‐kinase (PI3K): Current and future prospects
- (2020) Carlos Alberto Manssour Fraga et al. ChemMedChem
- Paradigm Shift of “Classical” HDAC Inhibitors to “Hybrid” HDAC inhibitors in Therapeutic Interventions
- (2020) Gargi Nikhil Vaidya et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors
- (2020) Amr K.A. Bass et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Bifunctional HDAC Therapeutics: One Drug to Rule Them All?
- (2020) Joshua P. Smalley et al. MOLECULES
- Discovery of Highly Selective and Potent HDAC3 Inhibitors Based on a 2-Substituted Benzamide Zinc Binding Group
- (2020) Jian Liu et al. ACS Medicinal Chemistry Letters
- Epigenetic regulation of post-embryonic development
- (2020) Subba Reddy Palli Current Opinion in Insect Science
- Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment
- (2020) Xiaopeng Peng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Non-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy
- (2020) Sonali Kumar et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
- (2020) Yuxiang Luo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HDAC6 as privileged target in drug discovery: A perspective
- (2020) Sravani Pulya et al. PHARMACOLOGICAL RESEARCH
- HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics
- (2020) Carlla Assis Araujo-Silva et al. International Journal for Parasitology-Drugs and Drug Resistance
- Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology
- (2019) Rashmi R. Shah DRUG SAFETY
- A Click Chemistry Approach Reveals the Chromatin-Dependent Histone H3K36 Deacylase Nature of SIRT7
- (2019) Wesley Wei Wang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A comparative safety review of histone deacetylase inhibitors for the treatment of myeloma
- (2019) Guldane Cengiz Seval et al. Expert Opinion On Drug Safety
- Small molecule HDAC inhibitors: Promising agents for breast cancer treatment
- (2019) Meiling Huang et al. BIOORGANIC CHEMISTRY
- HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer
- (2019) Yue Xue et al. BRITISH JOURNAL OF CANCER
- Valproic acid promotes the epithelial-to-mesenchymal transition of breast cancer cells through stabilization of Snail and transcriptional upregulation of Zeb1
- (2019) Siyuan Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Class I Histone Deacetylase Inhibition by Tianeptinaline Modulates Neuroplasticity and Enhances Memory
- (2018) Wen-Ning Zhao et al. ACS Chemical Neuroscience
- Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
- (2018) Ka Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on isocombretastatin A-4
- (2018) Diana Lamaa et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors
- (2018) et al. MOLECULES
- Combined alkylation and histone deacetylase inhibition with EDO-S101 has significant therapeutic activity against brain tumors in preclinical models
- (2018) Yushi Qiu et al. Oncotarget
- New 5-Aryl-Substituted 2-Aminobenzamide-Type HDAC Inhibitors with a Diketopiperazine Group and Their Ameliorating Effects on Ischemia-Induced Neuronal Cell Death
- (2018) Yoshiyuki Hirata et al. Scientific Reports
- Design and synthesis of potent dual inhibitors of JAK2 and HDAC based on fusing the pharmacophores of XL019 and vorinostat
- (2018) Yu-yi Chu-Farseeva et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discerning evolutionary trends in post-translational modification and the effect of intrinsic disorder: Analysis of methylation, acetylation and ubiquitination sites in human proteins
- (2018) Mohanalakshmi Narasumani et al. PLoS Computational Biology
- Structure, Functions and Selective Inhibitors of HDAC6
- (2018) Tao Liang et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies
- (2018) Bastian von Tresckow et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy
- (2018) Yepeng Luan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides
- (2018) Alberto Bresciani et al. ACS Medicinal Chemistry Letters
- Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model
- (2017) WG Singleton et al. International Journal of Nanomedicine
- Histone deacetylase 10 structure and molecular function as a polyamine deacetylase
- (2017) Yang Hai et al. Nature Communications
- Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models
- (2016) Pengyu Huang et al. Oncotarget
- Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors
- (2015) Johanna Senger et al. JOURNAL OF MEDICINAL CHEMISTRY
- An azumamide C analogue without the zinc-binding functionality
- (2014) Jesper S. Villadsen et al. MedChemComm
- Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group
- (2012) Chris J. Vickers et al. ACS Medicinal Chemistry Letters
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now